This article is part of our coverage of the 2019 Morningstar Investment Conference.
Innovations in drug technologies are accelerating, promising improved outcomes for patients. However, the costs of many of these drugs are staggering. That contributes to the need for careful financial planning that encompasses the expense of healthcare in retirement. Three Morningstar experts addressed these issues at the Morningstar Investment Conference.
To view this article, become a Morningstar Basic member.
Laura Lallos does not own shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.